Verastem Cancer Drug Shows Responses in Pancreatic, Lung, and Colorectal Cancers
Verastem Oncology (VSTM) said Wednesday that early data from its trial of VS-7375, a drug targeting
Keep reading this article with Yahoo Finance Plus Silver
Silver
- Premium news Full access to Financial Times and MT Newswires articles
- Stock picks Expert picks from Motley Fool, Zacks, and Moby
- Research reports Expert analysis from Morningstar and Argus
